This report describes a new experimental model to evaluate the effect of a recurrent systemic inflammatory challenge, after cerebral hypoxiaischemia in immature mice, on the progression of brain injury. Treatment with a low dose of lipopolysaccharide (E. coli O55:B5, 0.2 mg/kg for 3 days, then 0.1 mg/kg for 2 days) daily for 5 days after unilateral cerebral hypoxia-ischemia (right carotid ligation followed by 35 min in 10% O 2 ) in 10-day-old mice resulted in increased right forebrain tissue damage (35.6% reduction in right hemisphere volume compared to 20.6% reduction in saline-injected controls), in bilateral reductions in corpus callosum area (by 12%) and myelin basic protein immunostaining (by 19%), and in suppression of injury-related right subventricular zone cellular proliferation. The post-hypoxic-ischemic lipopolysaccharide regimen that amplified brain injury was not associated with increased mortality, nor with changes in body temperature, weight gain or blood glucose concentrations. The results of the present study demonstrate that systemic inflammation influences the evolution of tissue injury after neonatal cerebral hypoxia-ischemia and may also impair potential recovery mechanisms.
Introduction
There is now substantial epidemiologic and experimental evidence that pre-existing intrauterine inflammation can potentiate prenatal hypoxic-ischemic (HI) brain injury (Yoon et al., 1997; Nelson et al., 1998; Wu et al., 2003; Eklind et al., 2001; Lehnardt et al., 2003; Yang et al., 2004) . However, the postnatal environment of critically ill newborns is also fraught with risks of pro-inflammatory challenges. Such systemic inflammatory stimuli include sepsis, pneumonia, sustained acute lung injury, necrotizing enterocolitis and its complications, and major abdominal or thoracic surgery. Given the critical role of inflammatory mediators in the pathogenesis of experimental neonatal hypoxic-ischemic brain injury (Barks and Silverstein, 2002) , and the immaturity of the blood-brain barrier (Risau and Wolburg, 1990; Stolp et al., 2005) , we hypothesized that systemic inflammation might increase the severity of brain injury after an acute cerebral hypoxicischemic insult. The impact of post-hypoxic-ischemic systemic inflammation on the evolution of neonatal brain injury has not previously been evaluated in an experimental model. This report describes a new neonatal mouse model in which to study the impact of postnatal systemic inflammation on the evolution of hypoxic-ischemic brain injury. Hypoxic-ischemic brain injury was elicited using a well-established model of carotid ligation followed by hypoxia exposure in 10-day-old (P10) mice (Liu et al., 1999) , which is a modification of the Rice-Vannucci model originally described in immature rats (Rice et al., 1981) . We utilized a regimen of five sequential daily injections of low doses of lipopolysaccharide (LPS) to elicit systemic inflammation. In contrast with previous studies, in which single doses of LPS were administered prior to a CNS insult to model the effects of pre-or perinatal systemic inflammation on HI-or seizure-induced injury to the immature brain (Eklind et al., 2001; Lehnardt et al., 2003; Sankar et al., 2007) , in our model, the first LPS injection was administered at 2 h after hypoxic-ischemic lesioning.
